In the aim of searching for new molecules, potentially effective against strains resistant to conventional antifungal drugs, we investigated the in vitro activity of a KT produced by the recently isolated W. anomalus strain 1F1 (Wa1F1-KT)  against both susceptible and azole-resistant clinical isolates as well as laboratory strains of C. albicans and C. glabrata displaying known mutations .